CHTOP and diabetes mellitus: We identified an intragenic CpG site in the gene encoding chromatin target of PRMT1 (CHTOP) that exhibits complementary tissue specificity to INS and may be used to increase confidence of detecting islet damage in youth with prediabetes and diabetes.